Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease. Kondo R, Austin J, Akel M, Arora VM, et al. J Asthma 2023;60:323-330.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kondo R, Austin J, Akel M, Arora VM, et al. Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease. J Asthma 2023;60:323-330.
PMID: 35230210